Signs that the Federal Trade Commission (FTC) in the US may be softening its stance on pharma deals seem to have been misread, as the regulator has now sued to block Sanof
Novartis has settled a lawsuit brought by Daiichi Sankyo’s Plexxikon subsidiary, paying $180 million to resolve claims that its Tafinlar cancer drug infringed US patents h
The Apple Watch is facing the threat of a US import ban in the wake of an International Trade Commission (ITC) ruling that it violated patents held by Masimo on the use of
Indivior has reached an agreement to settle all outstanding claims over allegations of improper marketing of its opioid use disorder drug Suboxone Film in the US.
Daiichi Sankyo has been ordered to pay an 8% royalty rate on sales of its breast cancer therapy Enhertu by a Texas court, on top of an earlier award of $41.8 million in da
